Research from Reading may help to design better gene therapy vectors – University of Reading
06 October 2008Research published by scientists from the University of Reading may offer an insight into ways of making safer and more specific gene therapy vectors. The research, published in the journal Nature Structural and Molecular Biology, describes the structure of the viral fusion protein gp64, which is involved in the mechanism which viruses use to invade host cells. In the past, Bacloviruses have been suggested as possible gene therapy vectors due to the way in which they enter host cells, but there has been little evidence which explain these properties up to now.
Viruses are unable to grow or reproduce outside a host cell. Entry of a virus into a living cell is driven by molecules on the virus' envelope known as viral fusion proteins. Bacloviruses are a group of viruses which primarily infect invertebrate cells. One of the viral fusion proteins found on Baclovirus is gp64. It is necessary for cell entry and mediates receptor binding, a decrease in pH which triggers membrane fusion and facilitates Baclovirus entry into many types of mammalian cells. Another interesting property of gp64 is that it can also easily incorporate peptides into the virus DNA. Taken together, this suggests that Baclovirus may be a useful gene-delivery vector.
Gene therapy is the insertion of genes into an individual's cells and tissues to treat a disease in which defective genes are replaced with functional ones. In the future, gene therapy may be able to provide potential cures to diseases such as cystic fibrosis, hemophilia, muscular dystrophy and sickle cell anemia. In order for the therapy to work, the gene must be incorporated into the genome and a carrier, or vector, must be used. One of the problems with the use of gene therapy at the moment is that the vectors available are largely considered to be unsafe, and this research may therefore offer ways of making safer and more specific gene therapy vectors.
The research was carried out in collaboration with scientists at the University of Oxford and EMBL Grenoble. Professor Ian Jones from the School of Biological Sciences at the University of Reading said "this research has greatly increased our understanding about viral fusion proteins and how viruses get into cells. We hope that in the future this may lead to safer and more specific gene therapy vectors."
ENDS
Notes to editors
For more information please contact Dr Lucy Chappell on 0118 378 7391 or 0751 518 8751 or email l.chappell@reading.ac.uk
This research is published in Nature Structural and Molecular Biology
The University of Reading is ranked as one of the UK's top research-intensive universities. The quality and diversity of the University's research and teaching is recognised internationally as one of the top 200 universities in the world. The University is home to more than 50 research centres, many of which are recognised as international centres of excellence such as agriculture, biological and physical sciences, European histories and cultures, and meteorology.
The most recent Research Assessment Exercise confirms our strengths, with 20 departments being awarded top ratings of 5 or above. Of these, Archaeology, English, Italian, Meteorology and Psychology each received a 5** rating in recognition of their high quality sustained over more than a decade. The University takes a real-world perspective to its research and is consistently one of the most popular higher education choices in the UK